| Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH) (NCT05303506) | Assiut University | 2022-07-02 |
| The Safety and Efficiency of Luspatercept in Chinese Adults With Transfusion Dependent β-thalassemia: a Real-world Study (NCT05462548) | Sun Yat-sen University | 2022-07-01 |
| EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) (NCT05444894) | Editas Medicine, Inc. | 2022-04-29 |
| β-globin Restored Autologous HSC in β-thalassemia Major Patients (NCT04205435) | Bioray Laboratories | 2021-11-01 |
| Safety and Efficacy Evaluation of γ-globin Reactivated Autologous Hematopoietic Stem Cells (NCT04211480) | Bioray Laboratories | 2020-10-01 |
| Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases (NCT04526405) | University of Milano Bicocca | 2020-07-14 |
| Pilot Study PBSCT With TCRab Depletion For Hemoglobinopathies (NCT04523376) | Timothy Olson | 2020-05-14 |
| Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia (NCT04292314) | Beni-Suef University | 2019-11-01 |
| Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation (NCT03637556) | DisperSol Technologies, LLC | 2019-08-20 |
| Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study (NCT04009525) | First Affiliated Hospital of Guangxi Medical University | 2019-07-05 |
| The Effect of N-acetylcysteine on Oxidative Stress Status and Iron Overload in Thalassemia Major (NCT04260516) | Beni-Suef University | 2019-06-03 |
| Observing the Changes of Endocrine and Metabolism in Patients With Thalassemia Major (NCT03951818) | National Taiwan University Hospital | 2019-04-01 |
| Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital (NCT03161899) | Assiut University | 2018-12-15 |
| Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients (NCT03992001) | Università degli Studi di Ferrara | 2018-05-14 |
| In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM) (NCT02986698) | University of California, San Francisco | 2017-10-05 |
| Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major (NCT03171831) | First Affiliated Hospital of Guangxi Medical University | 2017-04-01 |
| Periodontal Therapy in Thalassemia Major Patients (NCT03311243) | King Saud University | 2016-01-11 |
| Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis (NCT02559648) | Ersi Voskaridou | 2014-09-01 |
| Long Term Outcomes in β Thalassemia Major (NCT02307786) | Ann & Robert H Lurie Children's Hospital of Chicago | 2014-06-01 |
| Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia. (NCT02049450) | Novartis Pharmaceuticals | 2014-05-28 |
| Role of Vitamin C to Augment Iron Chelation With DFP or DFX (NCT02083575) | Ain Shams University | 2014-04-01 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in β-Thalassemia Major Participants (NCT01745120) | Genetix Biotherapeutics Inc. | 2013-08-01 |
| MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent Anemias (NCT02090699) | University Health Network, Toronto | 2013-07-01 |
| "Iron Overload and Endocrinological Diseases" (NCT06137079) | Azienda Ospedaliero-Universitaria di Modena | 2013-06-20 |
| An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years Old (NCT01724138) | Novartis Pharmaceuticals | 2013-06-01 |
| Reproductive Capacity and Iron Burden in Thalassemia (NCT02308904) | UCSF Benioff Children's Hospital Oakland | 2013-06-01 |
| Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC Transfusion (NCT01740531) | Cerus Corporation | 2012-12-01 |
| Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia Major (NCT02126046) | Nanfang Hospital, Southern Medical University | 2012-09-01 |
| Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia (NCT01496963) | Ente Ospedaliero Ospedali Galliera | 2012-01-01 |
| The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response Study (NCT01323608) | Weill Medical College of Cornell University | 2011-06-01 |
| High-Tc Susceptometer to Monitor Transfusional Iron Overload (NCT01241357) | Columbia University | 2011-03-01 |
| B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals (NCT01846923) | Aghia Sophia Children's Hospital of Athens | 2010-10-01 |
| Perceptions of Thalassemia Major in Singapore: An Exploratory Study of Stigma (NCT01129076) | National Human Genome Research Institute (NHGRI) | 2010-04-23 |
| Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major (NCT01125254) | University of Campinas, Brazil | 2008-09-01 |
| Pilot Study for Patients With Poor Response to Deferasirox (NCT00749515) | Boston Children's Hospital | 2008-03-01 |
| Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major (NCT00480506) | Dana-Farber Cancer Institute | 2004-04-01 |
| Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI (NCT01140321) | Ente Ospedaliero Ospedali Galliera | 2004-01-01 |
| A 4-year Extension Study to Core 1-year Study of Iron Chelation Therapy With Deferasirox in β-thalassemia Major Pediatric Patients With Transfusional Iron Overload. (NCT00390858) | Novartis Pharmaceuticals | 2003-09-01 |
| Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia (NCT00034528) | National Institute of Allergy and Infectious Diseases (NIAID) | 2001-09-01 |
| Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders (NCT00005893) | Fairview University Medical Center | 2000-06-01 |
| Stem Cell Transplantation (SCT) for Genetic Diseases (NCT00004378) | National Center for Research Resources (NCRR) | 1995-01-01 |